Humanigen Inc (HGENQ)

[agmcsf]

I have two questions:

1. Humanigen spend 4 months (5-9) to recruit 150 patients from US sites in the phase III trial. Even with the help of Brazil sites, how do Humanigen manage to enroll another 150 patients in one month?

2. If humanigen managed to finish enroll patients before the end of september, it means that they can push the speed to about 2.5 patients per day in the US. But they didn’t do that, and it delays the phase 3 trials to a point that hurt the share price. Do humanigen have a good explanation for this?